This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.
As expected there are different reactions to President Rodrigo Duterte’s reasons to continue the war on drugs, especially when he said in his SONA that it is because of his concern for human lives. There are those…
At least two senators on Sunday urged the Philippine National Police (PNP) to heed the call of the Supreme Court (SC) and submit investigation reports on the killing of drug suspects in President Rodrigo Duterte’s war on…
MANCHESTER, New Hampshire — Embracing the tough penalties favored by global strongmen, US President Donald Trump on Monday brandished the death penalty as a fitting punishment for drug traffickers fueling the opioid epidemic. The scourge has torn…
Senator Bam Aquino on Tuesday slammed the dismissal of illegal drugs charges against Cebu businessman and self-confessed drug trafficker Kerwin Espinosa as proof that the war on drugs only targets the poor. In a resolution dated on…
Should reporters and correspondents join anti-drug operations if only to prove that there are no killings of drug suspects contrary to claims of their families and rights groups? That’s the question that arose after President Rodrigo Duterte…
Mandaue City’s first drug surrenderer killed in broad daylight Barely two weeks after he told reporters in an interview in his cell that he continued to fear for his life because he was on the police hit…
CEBU CITY–Cebu Archbishop Jose Palma has expressed concern over the rising death toll on the administration’s war on prohibited drugs. He said killing suspected criminals is not the right antidote to the country’s problem on illegal drugs…
MANILA — President Duterte has belittled the decision of the US State Department to call off the sale of 26,000 assault rifles to the Philippine National Police, saying the Philippines could just turn to Russia for firearms.…
This is an information message
We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.